These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Phenotypic manifestations of inflammatory bowel disease differ between Hispanics and non-Hispanic whites: results of a large cohort study. Damas OM; Jahann DA; Reznik R; McCauley JL; Tamariz L; Deshpande AR; Abreu MT; Sussman DA Am J Gastroenterol; 2013 Feb; 108(2):231-9. PubMed ID: 23247580 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996. Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451 [TBL] [Abstract][Full Text] [Related]
4. Demographic and Clinical Characteristics of a Predominantly Hispanic Population with Inflammatory Bowel Disease on the US-Mexico Border. Mendoza Ladd A; Jia Y; Yu C; Elhanafi S; Dwivedi A; Liu J; Song G; Hall M; Zuckerman MJ South Med J; 2016 Dec; 109(12):792-797. PubMed ID: 27911976 [TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease characteristics in Hispanic children in Texas. Hattar LN; Abraham BP; Malaty HM; Smith EO; Ferry GD Inflamm Bowel Dis; 2012 Mar; 18(3):546-54. PubMed ID: 21456045 [TBL] [Abstract][Full Text] [Related]
6. Hispanic Americans and Non-Hispanic White Americans Have a Similar Inflammatory Bowel Disease Phenotype: A Systematic Review with Meta-Analysis. Avalos DJ; Mendoza-Ladd A; Zuckerman MJ; Bashashati M; Alvarado A; Dwivedi A; Damas OM Dig Dis Sci; 2018 Jun; 63(6):1558-1571. PubMed ID: 29594975 [TBL] [Abstract][Full Text] [Related]
7. Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Hou JK; El-Serag H; Thirumurthi S Am J Gastroenterol; 2009 Aug; 104(8):2100-9. PubMed ID: 19471256 [TBL] [Abstract][Full Text] [Related]
8. Latin Americans and US Hispanics show differences in IBD phenotype: a systematic review with meta-analysis. Avalos DJ; Satiya J; Contreras A; Trivedi S; Alvarado L; Dodoo C; Dwivedi AK; Zuckerman MJ J Investig Med; 2022 Apr; 70(4):919-933. PubMed ID: 34933995 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory bowel disease characteristics and treatment in Hispanics and Caucasians. Hou J; El-Serag H; Sellin J; Thirumurthi S Dig Dis Sci; 2011 May; 56(5):1476-81. PubMed ID: 21394463 [TBL] [Abstract][Full Text] [Related]
10. High prevalence of inflammatory bowel disease in United States residents of Indian ancestry. Malhotra R; Turner K; Sonnenberg A; Genta RM Clin Gastroenterol Hepatol; 2015 Apr; 13(4):683-9. PubMed ID: 25083563 [TBL] [Abstract][Full Text] [Related]
11. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort. Burisch J Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years - United States, 2015. Dahlhamer JM; Zammitti EP; Ward BW; Wheaton AG; Croft JB MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(42):1166-1169. PubMed ID: 27787492 [TBL] [Abstract][Full Text] [Related]
13. Racial/Ethnic and regional differences in the prevalence of inflammatory bowel disease in the United States. Wang YR; Loftus EV; Cangemi JR; Picco MF Digestion; 2013; 88(1):20-5. PubMed ID: 23797316 [TBL] [Abstract][Full Text] [Related]
14. Hispanics Coming to the US Adopt US Cultural Behaviors and Eat Less Healthy: Implications for Development of Inflammatory Bowel Disease. Damas OM; Estes D; Avalos D; Quintero MA; Morillo D; Caraballo F; Lopez J; Deshpande AR; Kerman D; McCauley JL; Palacio A; Abreu MT; Schwartz SJ Dig Dis Sci; 2018 Nov; 63(11):3058-3066. PubMed ID: 29982988 [TBL] [Abstract][Full Text] [Related]
15. Genetic Characterization and Influence on Inflammatory Bowel Disease Expression in a Diverse Hispanic South Florida Cohort. Damas OM; Gomez L; Quintero MA; Rampersaud E; Slifer S; Beecham GW; Kerman DH; Deshpande AR; Sussman DA; Abreu MT; McCauley JL Clin Transl Gastroenterol; 2017 Apr; 8(4):e87. PubMed ID: 28406493 [TBL] [Abstract][Full Text] [Related]
16. Manifestations of inflammatory bowel disease in patients of Haitian and Cape Verdean descent. Stallwood C; Shergill K; Wu J; Farraye FA; Miller HL Scand J Gastroenterol; 2015 Jul; 50(7):832-40. PubMed ID: 25652938 [TBL] [Abstract][Full Text] [Related]
17. Differences in prevalence of inflammatory bowel disease in Puerto Rico between commercial and government-sponsored managed health care insured individuals. Vendrell R; Venegas HL; Pérez CM; Morell C; Roman RV; Torres EA Bol Asoc Med P R; 2013; 105(2):15-9. PubMed ID: 23882984 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of Inflammatory Bowel Disease Among Medicare Fee-For-Service Beneficiaries - United States, 2001-2018. Xu F; Carlson SA; Liu Y; Greenlund KJ MMWR Morb Mortal Wkly Rep; 2021 May; 70(19):698-701. PubMed ID: 33983913 [TBL] [Abstract][Full Text] [Related]
19. A national survey on the patterns of treatment of inflammatory bowel disease in Canada. Hilsden RJ; Verhoef MJ; Best A; Pocobelli G BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168 [TBL] [Abstract][Full Text] [Related]
20. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]